USCAX
Price
$17.28
Change
-$0.11 (-0.63%)
Updated
Aug 10 closing price
Net Assets
995.1M
VSCPX
Price
$421.90
Change
-$1.38 (-0.33%)
Updated
Aug 10 closing price
Net Assets
183.38B
Interact to see
Advertisement

USCAX vs VSCPX

USCAX vs VSCPX Comparison Chart in %
View a ticker or compare two or three
VS
USCAX vs. VSCPX commentary
Aug 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USCAX is a Buy and VSCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCPX has more cash in the bank: 183B vs. USCAX (995M). VSCPX pays higher dividends than USCAX: VSCPX (1.24) vs USCAX (0.24). USCAX was incepted earlier than VSCPX: USCAX (27 years) vs VSCPX (16 years). USCAX (1.01) is less costly to investors than VSCPX (0.02). USCAX is a more actively managed with annual turnover of: 70.00 vs. VSCPX (17.00). USCAX has a lower initial minimum investment than VSCPX: USCAX (3000) vs VSCPX (100000000). USCAX annual gain was more profitable for investors over the last year : 32.76 vs. VSCPX (27.86). VSCPX return over 5 years is better than : 38.66 vs. USCAX (-17.92).
USCAXVSCPXUSCAX / VSCPX
Total Expense Ratio1.010.025,050%
Annual Report Gross Expense Ratio1.010.025,050%
Fund Existence27 years16 years-
Gain YTD29.29418.865155%
Front LoadN/AN/A-
Min. Initial Investment30001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets995M183B1%
Annual Yield % from dividends0.241.2419%
Returns for 1 year32.7627.86118%
Returns for 3 years40.4453.2476%
Returns for 5 years-17.9238.66-46%
Returns for 10 years9.65161.256%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYOIX90.69N/A
N/A
Rydex Biotechnology Inv
MRLRX22.17N/A
N/A
BlackRock Advantage Large Cap Core R
HAMVX34.43N/A
N/A
Harbor Mid Cap Value Instl
VBINX55.25N/A
N/A
Vanguard Balanced Index Inv
MAMEX23.64N/A
N/A
MoA Mid Cap Equity Index Fund